In ccRCC, MEXPRESS-based analysis indicated that EIF4A1 levels were related to clinicopathologic features including recurrence after initial treatment, TNM classification, tumor stage, sample type, smoking history, and overall survival (Figure 8B). This evidence concerns the gene EIF4A1 and neoplasm.